Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys.

Autor: WH Ettinger, LD Miller, JJ Albers, TK Smith, JS Parks

Publikováno v: Journal of Lipid Research, Vol 31, Iss 6, Pp 1099-1107 (1990)

The effects of intravenous injection of lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNF) were investigated in cynomolgus monkeys (Macaca fascicularis). Injection of 20 micrograms/kg of LPS from E. coli (serotype 055:B5) into cynomolgus

Externí odkaz: https://doaj.org/article/8c41840ae28c4725b691b9b8d13794ef

Observations on the stability of the oedema disease principle

Autor: DW Gregory, LD Miller, RL Muhm

Publikováno v: The Veterinary record. 97(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0eadc5d0f53807126df54b26f0fd7e
https://pubmed.ncbi.nlm.nih.gov/1098272

Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-Type Non-Small Cell Lung Cancer.

Autor: Smith MR; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Dixon CB; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Wang Y; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Liu Y; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., D'Agostino R Jr; Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Ruiz J; Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Oliver G; Department of Pharmacy, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina., Miller LD; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Topaloglu U; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Chan MD; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Farris M; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Su J; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana., Mileham KF; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Zhao D; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Li W; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Sexton T; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Lycan T; Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Haas KM; Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Grayson JM; Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Xing F; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Publikováno v: Cancer research [Cancer Res] 2024 Dec 02; Vol. 84 (23), pp. 4002-4016.

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancers.

Autor: Berry LK; Department of Obstetrics and Gynecology, Section on Gynecologic Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Pullikuth AK; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Stearns KL; Department of Obstetrics and Gynecology, Section on Gynecologic Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Wang Y; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Wagner CJ; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Chou JW; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, 27157, USA., Darby JP; Department of Obstetrics and Gynecology, Section on Gynecologic Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Kelly MG; Department of Obstetrics and Gynecology, Section on Gynecologic Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA., Mall R; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.; Biotechnology Research Center, Technology Innovation Institute, P.O. Box 9639, Abu Dhabi, United Arab Emirates., Leung M; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, 27157, USA., Chifman J; Department of Mathematics and Statistics, American University, Washington, DC, 20016, USA., Miller LD; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA. ldmiller@wakehealth.edu.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, 27157, USA. ldmiller@wakehealth.edu.

Publikováno v: Journal of translational medicine [J Transl Med] 2024 Nov 20; Vol. 22 (1), pp. 1048. Date of Electronic Publication: 2024 Nov 20.

A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer.

Autor: Mason M; Bristol Myers Squibb, Princeton, NJ, USA., Lapuente-Santana Ó; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands., Halkola AS; Department of Mathematics and Statistics, University of Turku, Turku, Finland., Wang W; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland., Mall R; Qatar Computing Research Institute, Hamad Bin Khalifa University, P.O. Box 34110, Doha, Qatar.; Department of Immunology, St. Jude Children's Research Hospital, P.O. Box 38105, Memphis, TN, USA.; Biotechnology Research Center, Technology Innovation Institute, P.O. Box 9639, Abu Dhabi, United Arab Emirates., Xiao X; School of Informatics, Xiamen University, Xiamen, China.; National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China., Kaufman J; Department of Medicine, Duke University, Durham, NC, USA.; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Fu J; Dana-Farber Cancer Institute, Boston, MA, USA., Pfeil J; AbbVie, South San Francisco, CA, USA., Banerjee J; Sage Bionetworks, Seattle, WA, USA., Chung V; Sage Bionetworks, Seattle, WA, USA., Chang H; Bristol Myers Squibb, Princeton, NJ, USA., Chasalow SD; Bristol Myers Squibb, Princeton, NJ, USA., Lin HY; Bristol Myers Squibb, Princeton, NJ, USA., Chai R; Sage Bionetworks, Seattle, WA, USA., Yu T; Sage Bionetworks, Seattle, WA, USA., Finotello F; Institute of Molecular Biology, University of Innsbruck, Innsbruck, Austria.; Digital Science Center (DiSC), University of Innsbruck, Innsbruck, Austria., Mirtti T; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; iCAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; Department of Biomedical Engineering, School of Medicine, Emory University, Atlanta, GA, USA., Mäyränpää MI; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Bao J; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland., Verschuren EW; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland., Ahmed EI; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar., Ceccarelli M; Department of Electrical Engineering and Information Technology (DIETI), University of Naples 'Federico II', 80125, Naples, Italy.; BIOGEM Institute of Molecular Biology and Genetics, Via Camporeale, Ariano Irpino, Italy., Miller LD; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Monaco G; BIOGEM Institute of Molecular Biology and Genetics, Via Camporeale, Ariano Irpino, Italy., Hendrickx WRL; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar., Sherif S; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar., Yang L; Dana-Farber Cancer Institute, Boston, MA, USA., Tang M; Dana-Farber Cancer Institute, Boston, MA, USA., Gu SS; Dana-Farber Cancer Institute, Boston, MA, USA., Zhang W; Dana-Farber Cancer Institute, Boston, MA, USA., Zhang Y; Dana-Farber Cancer Institute, Boston, MA, USA., Zeng Z; Dana-Farber Cancer Institute, Boston, MA, USA., Das Sahu A; Dana-Farber Cancer Institute, Boston, MA, USA., Liu Y; Dana-Farber Cancer Institute, Boston, MA, USA., Yang W; Aginome Scientific, Xiamen, China., Bedognetti D; Human Immunology Department, Sidra Medicine, P.O. Box 26999, Doha, Qatar.; College of Health and Life Sciences, Hamad Bin Khalifa University, P.O. Box 26999, Doha, Qatar.; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy., Tang J; Faculty of Medicine, Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Eduati F; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; Institute for Complex Molecular Systems (ICMS), Eindhoven University of Technology, Eindhoven, The Netherlands., Laajala TD; Department of Mathematics and Statistics, University of Turku, Turku, Finland.; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.; iCAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland.; FICAN West Cancer Centre, University of Turku and Turku University Hospital, Turku, Finland.; Department of Pharmacology, Anschutz Medical Campus, University of Colorado, Denver, CO, USA., Geese WJ; Bristol Myers Squibb, Princeton, NJ, USA., Guinney J; Tempus Labs, Chicago, IL, USA., Szustakowski JD; Bristol Myers Squibb, Princeton, NJ, USA., Vincent BG; Department of Medicine, Division of Hematology, Department of Microbiology and Immunology, Curriculum in Bioinformatics and Computational Biology, Computational Medicine Program, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. david.p.carbone@gmail.com.

Publikováno v: Journal of translational medicine [J Transl Med] 2024 Feb 21; Vol. 22 (1), pp. 190. Date of Electronic Publication: 2024 Feb 21.